KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Operating Margin (2016 - 2025)

Evolent Health has reported Operating Margin over the past 11 years, most recently at 87.1% for Q4 2025.

  • Quarterly results put Operating Margin at 87.1% for Q4 2025, down 8422.0% from a year ago — trailing twelve months through Dec 2025 was 21.86% (down 2027.0% YoY), and the annual figure for FY2025 was 21.86%, down 2027.0%.
  • Operating Margin for Q4 2025 was 87.1% at Evolent Health, down from 0.18% in the prior quarter.
  • Over the last five years, Operating Margin for EVH hit a ceiling of 3.67% in Q3 2022 and a floor of 87.1% in Q4 2025.
  • Median Operating Margin over the past 5 years was 2.52% (2023), compared with a mean of 6.31%.
  • Biggest five-year swings in Operating Margin: skyrocketed 10047bps in 2021 and later tumbled -8422bps in 2025.
  • Evolent Health's Operating Margin stood at 4.92% in 2021, then soared by 90bps to 0.49% in 2022, then plummeted by -682bps to 3.84% in 2023, then increased by 25bps to 2.88% in 2024, then crashed by -2928bps to 87.1% in 2025.
  • The last three reported values for Operating Margin were 87.1% (Q4 2025), 0.18% (Q3 2025), and 0.26% (Q2 2025) per Business Quant data.